Recent advances in research on Parkinsonism.
D000110:Acetylcholinesterase / Q000378:metabolism; D000328:Adult; D001058:Apomorphine / Q000627:therapeutic use; D001545:Benserazide / Q000008:administration & dosage; D001921:Brain / Q000201:enzymology / Q000378:metabolism; D001971:Bromocriptine / Q000627:therapeutic use; D002230:Carbidopa / Q000008:administration & dosage; D004296:Dopa Decarboxylase / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D009638:Norepinephrine / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism; D012642:Selegiline / Q000627:therapeutic use; D012701:Serotonin / Q000378:metabolism; D013373:Substance P / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D012642:Selegiline; D012701:Serotonin; D013373:Substance P; D001971:Bromocriptine; D007980:Levodopa; D005680:gamma-Aminobutyric Acid; D001545:Benserazide; D014446:Tyrosine 3-Monooxygenase; D000110:Acetylcholinesterase; D004296:Dopa Decarboxylase; D002230:Carbidopa; D001058:Apomorphine; D004298:Dopamine; D009638:Norepinephrine